Reid, Ian R. http://orcid.org/0000-0001-6021-5458
Article History
Accepted: 20 February 2020
First Online: 17 March 2020
Competing interests
: I.R.R. declares consultancy fees from Lilly, Amgen and Merck, as well as previous research funding from Merck and Amgen.